Extensive amplification of hematopoietic stem cells (HSCs) and their multipotent primitive progenitors (MPPs) in culture would greatly benefit not only clinical transplantation but also provide a potential tool to manipulate all cellular lineages derived from these cells for gene therapy and experimental purposes. Here, we demonstrate that mouse bone marrow cultures containing cells engineered to over-express NUP98-HOXB4 fusion protein support self-renewal of physiologically normal HSC and MPP for several weeks leading practically to their unlimited expansion. This allows time consuming and cumulative in vitro experimental manipulations without sacrificing their ability to differentiate in vivo or in vitro to any hematopoietic lineage.
Introduction
Adult bone marrow (BM) houses a tiny pool of hematopoietic stem cells (HSCs) that have the ability to maintain not only themselves but also all the rest of highly turning over blood lineages throughout the mammalian life (1, 2) . Hence, the ability to sustain HSC in tissue culture would allow serial introduction of gain or loss of function mutations efficiently in hematopoietic system. However, our failure to expand HSC in culture has hampered the use of this approach. In fact, BM suspension cultures lose rapidly their HSC content despite vigorous growth of progenitors and more differentiated cells at least for 3 weeks even in optimal cytokine milieu (3, 4) . Therefore, the phenomenon of stem cell exhaustion or senescence may set the limits that make it impossible even in principle to expand HSC in culture for longer periods (5) (6) (7) .
Mouse HSC do expand in vivo (8, 9) , at least up to 8000-fold, as shown by Iscove and Nawa (9) through serial transplantation experiments that assessed carefully the input and output contents of HSC in each transfer generation. Recently also in vitro approaches have been improved and refined culture conditions with new growth factors can now support up to 30-fold expansion of mouse HSC ex vivo (10) . However, since it is not clear to what extent external culture conditions can be improved, alternative but not mutually exclusive efforts to change the intrinsic properties of HSC have been taken. Seminal experiments in this respect by Humphries, Savageau and their colleagues have shown that ectopic expression of HOXB4 transcription factor in BM cells support the survival and expansion of HSC in vivo and importantly also in vitro (11) (12) (13) . By rigorously monitoring the HSC content in their cultures of HOXB4-transduced BM cells, they found that HSC could be expanded up to 41-fold in the 2-week liquid cultures (13) . HOXB4 belongs to a large family of HOX transcription factors that are crucial for the basic developmental processes in addition to their role in maintenance of different stem cell compartments.
Capitalizing on the findings of Humphries, Savageau and their colleagues, we have established long-term murine BM cultures of HOXB4-transduced cells (HOX cells) and monitored their stem cell content to find out how extensively genetically modified HSC and their multipotent primitive progenitors (MPPs) can be expanded in culture for experimental purposes. In addition and for comparison, we established BM cultures transduced with constructs encoding for Nucleoporin 98 (NUP)-HOXB4 (NUP cells) fusion protein again following the lead of Humphries et al. (14) who showed that ectopic expression of similar fusions promoted in vivo even more robust expansion and survival of HSC.
Many HOX family members when over-expressed ectopically in BM cells induce leukemias when transplanted in vivo (15) (16) (17) as already suggested by their dysregulated expression in hematological malignancies (18) (19) (20) . Similarly, many NUP98 HOX fusion products detected especially in acute myelogenous leukemias are leukemogenic when ectopically expressed in BM cells (14, 21, 22) . Importantly, however, over-expression of HOXB4 and NUP98-HOXB4 genes seems not to induce leukemias experimentally in mice keeping with the fact that fusion products of NUP98-HOXB4 have not been detected in leukemias (14, 22) . Interestingly, it is not clear mechanistically why the component of the nucleopore complex has so dramatic effect in hematopoiesis.
Here, we report that cultures containing HOXB4 and especially NUP98-HOXB4-transduced BM cells sustain physiologically normal HSC and their MPPs for long periods leading practically to their unlimited expansion and hence providing us convenient targets for the experimental manipulation of hematopoietic lineages.
Methods

Retroviral vectors
Portion encoding for human HOXB4 was transferred from MSCV-HOXB4-IRES-GFP [gift from Sauvageau (12) ] to LXSP retroviral vector to create LHOXB4SP. LXSP is a derivative of LXSN (23) in which puromycin-resistant gene was introduced in the place of neomycin gene. NUP98-HOXB4 fusion gene was created by amplifying NUP98 portion from plasmid pcDNA3.1-3 3 HA-NUP98-HOXA9 [gift from Nakamura (21)] and HOXB4 portion from MSCV-HOXB4-IRES-GFP. The fusion break point was that described by Pineault et al. (14) . The fusion product was then cloned into pMYc-IP retroviral vector (24) containing IRES-puromycin resistance gene to generate pMYc-NUP98-HOXB4-IP. In both of these final constructs, the expression of HOXB4 and NUP98-HOXB4 was driven from the retroviral long terminal repeat. Similarly, coding regions of ovalbumin (OVA), programmed death-1 ligands (PD-L) and 2 were amplified by PCR and cloned in pMYc-IG vector (24) . All constructs were verified by DNA sequencing.
Transduction of mouse BM cells
Protocol of Antonchuk et al. (13) was followed with minor modifications; retrovirus-containing supernatants were generated by transfection of Ecotropic Phoenix packaging cells instead of GP + E86 producer line and then used to spinoculate twice (days 2 and 3) BM cells, 3 3 10 5 per well, in 24-well plates. Transduced cells were selected for puromycin resistance (2 lg ml À1 ) 2 days after the last spin infection. BM and transduced cells were cultured in IMDM supplemented with 2% FCS, 0.03% Primatone (Quest, Naarden, The Netherlands), 2) into lethally irradiated recipients (Ly5.2). NUP cell contribution to the sustained and multilineage reconstitution was then measured 4 months later in blood (C). Robust HSC activity was only detectable in fraction which corresponds to LSK fraction. Multilineage repopulation was determined as in Fig. 3 (data not shown). One typical recipient out of four is shown. mIL-3, mIL-6 and mSCF. Supernatants from transfected X63 plasmacytoma lines provided the sources of IL-3 and IL-6 (25) . Stem cell factor (SCF) was produced in bacteria as NH 2 -terminal 6-HIS fusion protein. IL-3-and SCF-dependent HOXB4 lines were used to determine the factor concentrations for optimal growth. IL-6 was supplemented as 1:50 dilution of the original X63 supernatant in the absence of appropriate bioassay representing most likely great excess. Mice C57BL/6 (B6) congenic Ly5.1 and Ly5.2 mice (gift from Rolink) of 6-10 weeks were used. All mice were bred and maintained in the animal facility of the Nanyang Technological University under specific pathogen-free conditions. All animal experiments were carried out within institutional guidelines. For transplantation, the recipients B6-Ly5.2 were lethally irradiated with 1000 rad in two doses separated by 4 h. Twelve to twenty-four hours later, constant numbers of B6-Ly5. 
Antibodies and flow cytometry
FITC-, PE-and APC-labeled antibodies (Ly5.1, Sca-1, c-Kit, FcReI, CD27, Mac-1, CD11c, CD3, B220, Gr-1, PD-L1 and 2) were all purchased from eBiosciences (San Diego, CA, USA), Cell suspensions of blood, spleen, thymus and BM and of HOXB4 or NUP cultures were stained in ice-cold PBS supplemented with 2% FCS. Data were collected on FACSCalibur (Becton Dickinson) and analyzed with FlowJo software (Treestar, Ashland, OR, USA). All cell sortings were performed by FACSaria (Becton Dickinson).
In vitro cultures for derivation of dendritic cells and antigen presentation assay
Cultured cells were grown in the presence of granulocyte macrophage colony-stimulating factor (GM-CSF) (1:50 2) was analyzed 16 weeks after transplantation. B, T and myeloid cell compartments and main thymocyte subsets derived from cultured cells were analyzed in blood, spleen and thymus, respectively. Overall level of chimerism in each organ is shown above. To score monocytes and granulocytes, the gate was extended to include larger and more granular cells. -fold expansion). Four months later, BM cells from primary recipients were cultured further for 1 week and then injected (10 6 ) to lethally irradiated secondary recipients (Ly5.2). Again 4 months later, BM cells (10 6 ) from secondary recipients were transferred directly to lethally irradiated tertiary recipients (Ly5.2) and finally 4 months later the tertiary BM cells were isolated for analysis. Lower part shows the level of chimerism obtained from cultured cells in each transfer generation in BM. Three mice in each generation were analyzed with similar results. Multilineage reconstitution was determined as in Fig. 3 (data not shown) . dilution of transfected X63 plasmacytoma) (26) or FLT3L (10 ng ml À1 ) for 7 or 10 days, respectively. Dendritic cell (DC) generation was monitored by double staining using APClabeled anti-CD11c combined with PE-labeled anti-MHC class II, anti-CD11b (for myeloid-related DCs) or anti-B220 (for plasmacytoid DCs) using a FACSCalibur.
GM-SCF-derived DCs from NUP98-HOXB4 lines as well as from normal BM cells were in vitro pulsed with 100 lg ml 
Results
Generation of 'immortalized' lines
The protocol established by Antonchuk et al. (13) was followed to transduce BM cells from 5-Fluoracil-treated mice with standard retrovirus vectors coding either for HOXB4 or NUP98-HOXB4 proteins. Transduced cells were then maintained in six-well plates in SCF, IL-3 and IL-6 containing media at cell concentrations between 10 5 À 5 3 10 5 by feeding and splitting the cultures in five or six (in a new well) every 2-3 days-cells divided every 20-22 h (data not shown) maintaining robustly that rate regardless of the age of the culture (1 week to 3 months).
Phenotype of transduced cells
Cultured cells were monitored weekly for their surface phenotype in order to reveal potential telltale signs of culture 'evolution'. Snapshots of 4 week cultures representing typical phenotype are shown (Fig. 1A) . At this time, cells in normal cultures (untransduced) had died off or only some slow-growing mast cell precursors were present. Generally, NUP cells keep their primitive phenotype quite tightly being . These phenotypes were relatively stable through at least 3 months of culture (duration of the experiment) during which cultures kept robustly expanding in growth factor-dependent way (data not shown) and no further attempts to optimize culture conditions were made.
Transduced HSC have a normal cell surface phenotype
It is important to note that the phenotype does not necessarily have to represent some physiological BM sub-population since over-expression of HOXB4 or NUP98-HOXB4 can directly or indirectly influence the pattern of surface expression. However, like in the case of normal BM cells, all detectable HSC reside in LSK fraction of the HOX cells. This was shown by testing the presence of HSC in different sorted populations from 4-week-old HOX cultures (Fig. 1B) . Only LSK cells (Sca-1 + /c-Kit + /FcReI À ) gave sustained multilineage reconstitution in the presence of competitor cells in standard in vivo HSC assays (Fig. 1C and see below) . This also suggests that ectopic expression of HOX does not increase potential 'plasticity' of BM cells in such an extent that they would be able to dedifferentiate from more mature cells back to stem cell-like state.
Transduced cultures sustain their HSC content
Since our cultures seem to support phenotypically MPPs that could be generated continuously from HSC, we wanted to quantify the actual HSC content in our cultures. To do this, we exploited the competitive BM reconstitution assay whereby titrated numbers of cultured cells from B6-Ly5.1 mice were forced to compete against the constant number (2 3 10 5 ) of normal, freshly isolated congenic B6-Ly5.2 BM cells in lethally irradiated recipients (B6-Ly5.2) (27) . The level of reconstitution in the blood myeloid and lymphoid compartments were analyzed earliest 16 weeks after transplantation to avoid scoring short-term HSC (26, 28) and at the end point of a given experiment also lymphoid organs like thymus was analyzed in order to get further evidence for active and continuous lymphopoiesis. Small sizes of our experimental groups 2-3 mice in each prevented us to perform proper in vivo fluctuation analysis. Therefore, the last experimental dose giving the robust (>3%) and sustained multilineage reconstitution in every mouse within the group was considered to contain at least one HSC i.e. our measurement were estimates (Figs 2 and 3) .
Sampling of the cultures for their HSC content were started at day 25 when control i.e. untransduced BM cultures had stopped their vigorous growth and accumulated only adherent cells and some slowly growing mast cell precursors. At this time point, transduced cells had expanded ;2 25 -fold (;3 3 10 7 ) and hence our surprise that HSC could be measured in high frequency (Figs 2 and 3) . NUP cultures contained still at least 1 HSC/2 3 10 4 cultured cells representing only ;10-fold decrease in the frequency compared with that of initial cultures of 5-FU-treated BM cells measured to be 1/2000 (27) (Fig. 2, upper panel) . HOX cultures maintained HSC less well but still in easily detectable frequencies of 1/100 of the starting culture. Hence, in NUP cultures, HSC had expanded more than million fold (;3 3 10 6 ) while in HOX cultures they did so 10-fold less efficiently correlating nicely with the phenotypic analysis (Fig. 1) . Similar results were obtained with cultures initiated and propagated independently for 25 days, demonstrating that these cultures robustly and reproducibly sustain HSC (data not shown).
Since our cultures sustained HSC surprisingly well, we continued the cultures another 5 weeks (day 60) corresponding to ;2 60 -fold expansion (;10 18 -fold) before we measured again their HSC content. Although HOX cultures did not any more harbor easily detectable frequencies of HSC, NUP cultures still contained them at robust levels (at least 1/200 000) corresponding to ;100-fold reduction from the original frequency i.e. HSC were expanded ;10 16 -fold (Fig. 2, middle panel) . We failed to detect HSC in cultures continued for further 2 weeks (day 74, Fig. 2, lower panel) . Possibly, we could have found some HSC by injecting more cultured cells but it is clear that cultures gradually lose their genuine HSC despite vigorous factor-dependent growth. Pleasingly though these extensively cultured cells did not become leukemogenic either (no abnormal expansions in recipient mice) and hence our genetic manipulation and the long in vitro culture had not induced or selected such aggressive variants.
Serial transplantation of transduced cells
To further demonstrate the expansion and maintenance of HSC in our cultures, we have performed serial transplantation experiments (Fig. 4) . To challenge the system, we first cultured the HOXB4-transduced BM cells for 3 weeks i.e. expanded them about million fold and then injected them into congenic lethally irradiated mice (10 5 per mouse, without competitors). After 4 months, the BM cells were isolated and again cultured, now for 1 week and then injected to secondary recipients (10 6 per mouse). Again 4 months later, 10 6 BM cells from the secondary recipients without the culture were transferred to tertiary hosts and these were then analysed 4 months later for multilineage reconstitution (Fig. 4) . Recipients in every transfer generation were robustly reconstituted giving further support that real HSC were expanded. Again, we did not detect any gross hematological abnormalities in any of the recipients.
Functional in vitro differentiation of transduced cells
Since the cells from our long-term cultures were able to functionally repopulate all the lineages in vivo, to rescue lethally irradiated mice and to support T cell dependent antibody responses (data not shown), we wondered if they also retained their capacity to differentiate in vitro to desired lineages. To do this, we cultured the cells from a 4-week-old NUP line in the presence of GM-CSF or FLT3L to generate different types of DCs (myeloid-related and plasmacytoid DCs) and then compared their efficiency as antigen presenting cells to that of DCs derived similarly from normal BM (Fig. 5) . Encouragingly, NUP cells were able to efficiently generate both myeloid and plasmacytoid DCs with typical phenotypes (Fig. 5A ). In addition they stimulated T cells as well as their normal counterparts (Fig. 5B) .
Immortalized lines tolerate cumulative and time-consuming manipulations
To show the resilience of our system for cumulative and successive manipulations, we transduced a 3-week-old NUP line with a retrovirus coding for OVA-IRES-EGFP and then selected the green cells by cell sorting. Portion of these cells were then further transduced with a retrovirus coding for PD-L1 and again by cell sorting PD-L1-positive population was isolated and then further transduced and selected for PD-L2 expression (Fig. 6A) . Finally, they and OVA-only expressing controls were injected in lethally irradiated recipients that were sacrificed 3 weeks later and spleen DCs were isolated for in vitro functional assays. As shown in Fig. 6(B) , three successive genetic modifications followed by cell sortings did not compromise the ability of NUP cells to differentiate to functional DC (and to rescue lethally irradiated recipients) in vivo and that they continued to over-express OVA, PD-L1 and PD-L2 (Fig. 6B) . Surprisingly, these DC triggered as efficiently as OVA-only DC the proliferation of naive OVAspecific transgenic T cells although as expected they did not trigger effector cytokine secretion (H. Khameneh, C. Ruedl, in preparation). These results underscore the fact that NUP cultures are robust tolerating successive manipulations while maintaining their potential for differentiation.
Discussion
Here, we have extended earlier observations that ectopic expression of HOXB4 or its modified forms can sustain HSC activity (11) (12) (13) (14) . In fact, as shown here, it is in practice possible to 'immortalize' HSC and their MPPs by interfering their transcriptional circuitry without necessarily compromising their physiological function and importantly without inducing obvious malignant behavior. Therefore, in principal, it is possible to dramatically delay the exhaustion of HSC in culture. It is certainly worth the effort to try to decipher the relevant molecular pathways that are induced or enfeebled by the ectopic expression of HOXB4 and NUP98-HOXB4 (29) . The knowledge of these pathways would allow us not only to develop more specific and less drastic ways to manipulate HSC but also to understand and ultimately control hematological malignancies. Since these lines can behave as their normal counterparts in vitro and in vivo in all aspects tested, they provide us (especially NUP98-HOXB4-transduced BM cells) a practical tool to study any hematological lineage. These lines are easy to derive from any genetic background and since they sustain their repopulating properties for long time in culture they make time consuming procedures like genetic complementation and cell sorting possible providing high throughput alternative or preview to more cumbersome germ line manipulations. 
